Hemicrania continua

Journal of Orofacial Pain

Volumn 16, Issue 4, 2002, Pages 317-325

  Benoliel, Rafael ^a   Robinson, Sharon ^a   Eliav, Eli ^a   Sharav, Yair ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Chronic; Daily headache; Dental pain; Facial pain; Headache; Indomethacin

Indexed keywords

INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; CASE REPORT; CHRONIC DISEASE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MIGRAINE; REVIEW; TOOTH PAIN;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INDOMETHACIN; MIGRAINE DISORDERS; TOOTHACHE;

EID: 0036728301     PISSN: 10646655     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Olesen J, Bes A, Kunkel R, et al. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(suppl 7).
2. Silberstein SD, Lipton RB, Solomon S, Mathew NT. Classification of daily and near-daily headaches: Proposed revisions to the IHS criteria. Headache 1994;34(1):1-7.
3. Nappi G, Granella F, Sandrini G, Manzoni GC. Chronic daily headache. How should it be included in the IHS classification? Headache 1999;39:197-203.
4. Olesen J, Rasmussen BK. The International Headache Society classification of chronic daily and near-daily headaches: A critique of the criticism. Cephalalgia 1996;16(6):407-411.
5. Manzoni GC, Granella F, Sandrini G, Cavallini A, Zanferrari C, Nappi G. Classification of chronic daily headache by International Headache Society criteria: Limits and new proposals. Cephalalgia 1995;15(1):37-43.
6. Solomon S, Lipton RB, Newman LC. Evaluation of chronic daily headache - Comparison to criteria for chronic tension-type headache. Cephalalgia 1992;12(6):365-368.
7. Deleu D, Hanssens Y. Primary chronic daily headache: Clinical and pharmacological aspects. A clinic-based study in Oman. Headache 1999;39:432-436.
8. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: Field trial of revised IHS criteria. Neurology 1996;47(4):871-875. [See comments 1997;49(2):638-639.]
9. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: Field trial of revised IHS criteria. Neurology 1996;47(4):871-875. [See comments 1997;49(2):638-639.]
10. Sjaastad O, Spierings EL. "Hemicrania continua": Another headache absolutely responsive to indomethacin. Cephalalgia 1984;4(1):65-70.
11. Bordini C, Antonaci F, Stovner LJ, Schrader H, Sjaastad O. "Hemicrania continua": A clinical review. Headache 1991;31(1):20-26.
12. Newman LC, Lipton RB, Solomon S. Hemicrania continua: Ten new cases and a review of the literature. Neurology 1994;44(11):2111-2114. [See comments 1995;45(10):1948-1949; 45(12):2302-2303.]
13. Newman LC, Lipton RB, Solomon S. Hemicrania continua: Ten new cases and a review of the literature. Neurology 1994;44(11):2111-2114. [See comments 1995;45(10):1948-1949; 45(12):2302-2303.]
14. Newman LC, Lipton RB, Solomon S. Hemicrania continua: Ten new cases and a review of the literature. Neurology 1994;44(11):2111-2114. [See comments 1995;45(10):1948-1949; 45(12):2302-2303.]
15. Centonze V, Attolini E, Campanozzi F, et al. "Hemicrania continua": A new clinical entity or a further development from cluster headache? A case report. Cephalalgia 1987;7(3):167-168.
16. Iordanidis T, Sjaastad O. Hemicrania continua: A case report. Cephalalgia 1989;9(4):301-303.
17. Pareja JA, Palomo T, Gorriti MA, et al. Hemicrania continua. The first Spanish case: A case report. Cephalalgia 1990;10(3):143-145.
18. Pasquier F, Leys D, Petit H. "Hemicrania continua": The first bilateral case? Cephalalgia 1987;7(3):169-170.
19. Sjaastad O, Tjorstad K. "Hemicrania continua": A third Norwegian case. Cephalalgia 1987;7(3):175-177.
20. Spierings EL. The chronic paroxysmal hemicrania concept expanded. Headache 1988;28(9):597-598.
21. Zukerman E, Hannuch SN, Carvalho DS, Fragoso YD, Jenger KA. "Hemicrania continua": A case report. Cephalalgia 1987;7(3):171-173.
22. Evers S, Bahra A, Goadsby PJ. Coincidence of familial hemiplegic migraine and hemicrania continua? A case report. Cephalalgia 1999;19(5):533-535.
23. Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomie feature, including new cases. Brain 1997;120(Pt 1):193-209.
24. Pareja JA. Hemicrania continua: Ocular discomfort heralding painful attacks. Funct Neurol 1999;14(2):93-95.
25. Solomon S, Newman LC. Chronic daily bilateral headache responsive to indomethacin. Headache 1999;39:754-757.
26. Fragoso YD, Machado PC. Hemicrania continua with onset at an early age. Headache 1998;38(10):792-793.
27. Newman LC, Lipton RB, Russell M, Solomon S. Hemicrania continua: Attacks may alternate sides. Headache 1992;32(5):237-238.
28. Trucco M, Antonaci F, Sandrini G. Hemicrania continua: A case responsive to piroxicam-beta-cyclodextrin. Headache 1992;32(1):39-40.
29. Pareja JA. Hemicrania continua: Remitting stage evolved from the chrome form. Headache 1995;35(3):161-162.
30. Pareja JA, Palomo T, Gorriti MA, Pareja J, Espejo J. "Hemicrania episodica" - A new type of headache or a pre-chronic stage of hemicrania continua? Headache 1990;30(6):344-346.
31. Goadsby PJ. Short-lasting primary headaches: Focus on trigeminal automatic cephalgias and indomethacin-sensitive headaches. Curr Opin Neurol 1999;12(3):273-277.
32. Moskowitz MA. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 1993;43(6 Suppl 3):S16-S20.
33. Moskowitz MA. Trigeminovascular system. Cephalalgia 1992;12(3):127.
34. Moskowitz MA. The neurobiology of vascular head pain. Ann Neurol 1984;16(2):157-168.
35. Moskowitz MA, Cutrer FM. Possible importance of neurogenic inflammation within the meninges to migraine headaches. In: Fields HL, Liebeskind JC (eds). Progress in Pain Research and Management. Vol 1: Pharmacological approaches to the treatment of chronic pain: New concepts and critical issues: The Bristol-Myers Squibb Symposium on Pain Research. Seattle: IASP Press, 1994:43-49.
36. Pareja JA, White LR, Sjaastad O. Pathophysiology of headaches with a prominent vascular component. Pain Res Manage 1996;1(2):93-108.
37. Antonaci F. Chronic paroxysmal hemicrania and hemicrania continua: Orbital phlebography and MRI studies. Headache 1994;34(1):32-34.
38. Antonaci F, Sandrini G, Danilov A, Sand T. Neurophysiological studies in chronic paroxysmal hemicrania and hemicrania continua. Headache 1994;34(8):479-483.
39. Antonaci F, Sand T, Sjaastad O. Hemicrania continua and chronic paroxysmal hemicrania: A comparison of pupillometric findings. Funct Neurol 1992;7(5):385-389.
40. Sjaastad O, Spierings EL, Saunte C, Wysocka Bakowska MM, Sulg I, Fredriksen TA. "Hemicrania continua." An indomethacin responsive headache. II. Autonomic function studies. Cephalalgia 1984;4(4):265-73.
41. Antonaci F. The sweating pattern in "hemicrania continua". A comparison with chronic paroxysmal hemicrania. Funct Neurol 1991;6(4):371-375.
42. Benoliel R, Sharav Y. Paroxysmal hemicrania. Case studies and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85(3):285-292.
43. Sjaastad O, Joubert J, Elsas T, Bovim G, Vincent M. Hemicrania continua and cervicogenic headache. Separate headaches or two faces of the same headache? Funct Neurol 1993;8(2):79-83.
44. Sjaastad O, Stovner LJ, Stolt-Nielsen A, Antonaci F, Fredriksen TA. CPH and hemicrania continua: Requirements of high indomethacin dosages - An ominous sign? Headache 1995;35(6):363-367.
45. Rothbart P. Unilateral headache with features of hemicrania continua and cervicogenic headache - A case report. Headache 1992;32(9):459-460.
46. Antonaci F, Pareja JA, Caminero AB, Sjaastad O. Chronic paroxysmal hemicrania and hemicrania continua: Anaesthetic blockades of pericranial nerves. Funct Neurol 1997;12(1):11-15.
47. Benoliel R, Elishoov H, Sharav Y. Orofacial pain with vascular-type features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84(5):506-512.
48. Antonaci F, Sjaastad O. Chronic paroxysmal hemicrania (CPH): A review of the clinical manifestations. Headache 1989;29(10):648-656.
49. Bittar G, Graff-Radford SB. A retrospective study of patients with cluster headaches. Oral Surg Oral Med Oral Parhol 1992;73(5):519-525.
50. Brooke RI. Periodic migrainous neuralgia: A cause of dental pain. Oral Surg Oral Med Oral Pathol 1978;46(4): 511-516.
51. Antonaci F, Sjaastad O. Hemicrania continua: A possible symptomatic case, due to mesenchymal tumor. Funct Neurol 1992;7(6):471-474.
52. Warner JS. Analgesic rebound as a cause of hemicrania continua. Neurology 1997;48(6):1540-1541.
53. Young WB, Silberstein SD. Hemicrania continua and symptomatic medication overuse. Headache 1993;33(9): 485-487.
54. Mirsattari SM, Power C, Nath A. Primary headaches in HIV-infected patients. Headache 1999;39:3-10.
55. Brilla R. Evers S, Soros P, Husstedt IW. Hemicrania continua in an HIV-infected outpatient. Cephalalgia 1998;18(5):287-288.
56. Lay CL, Newman LC. Posttraumatic hemicrania continua. Headache 1999;39:275-279.
57. Benoliel R, Eliav E, Elishoov H, Sharav Y. Diagnosis and treatment of persistent pain after trauma to the head and neck. J Oral Maxillofac Surg 1994;52(11):1138-1147; discussion 1147-1148.
58. Pareja J, Sjaastad O. Chronic paroxysmal hemicrania and hemicrania continua. Interval between indomethacin administration and response. Headache 1996;36(1):20-23.
59. Antonaci F, Pareja JA, Caminero AB, Sjaastad O. Chronic paroxysmal hemicrania and hemicrania continua. Parenteral indomethacin: The 'indotest'. Headache 1998;38(2):122-128.
60. Kuritzky A. Indomethacin-resistant hemicrania continua. Cephalalgia 1992;12(1):57-59.
61. Kumar KL, Bordiuk JD. Hemicrania continua: A therapeutic dilemma [letter]. Headache 1991;31(5):345.
62. Sjaastad O, Antonaci F. A piroxicam derivative partly effective in chronic paroxysmal hemicrania and hemicrania continua. Headache 1995;35(9):549-550.
63. Antonaci F, Pareja JA, Caminero AB, Sjaastad O. Chronic paroxysmal heinicrania and hemicrania continua: Lack of efficacy of sumatriptan. Headache 1998;38(3):197-200.
64. Insel PA. Analgesic-antipyretic and and inflammatory drugs employed in the treatment of gout. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW (eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York: McGraw-Hill, 1996:633-634.
65. Tfelt-Hansen P, Stewart Johnson E. Nonsteroidal antiinflammatorry drugs in the treatment of the acute migraine attack. In: Olesen J, Tfelt-Hansen P, Welch KMA (eds). The Headaches. New York: Raven Press, 1993:305-311.
66. Speziale MV, Allen RG, Henderson CR, Barrington KJ, Finer NN. Effects of ibuprofen and indomethacin on the regional circulation in newborn piglets. Biol Neonate 1999;76(4):242-252.
67. Wennmalm A, Carlsson A, Edlund S, Eriksson L, Kaijser L, Nowak J. Central and peripheral haemodynamic effects of non-steroidal anti-inflammatory drugs in man. Arch Toxicol Suppl 1984;7:350-359.
68. Vincent MB. Cyclooxygenase inhibitors modify the relaxant effect of vasoactive intestinal polypeptide and substance P in isolated porcine ophthalmic artery. Cephalalgia 1992;12(1):15-19.
69. Bakken IJ, Vincent MB, White LR, Cappelen J, Skaanes KO, Sjaastad O. Low concentrations of lithium and cyclooxygenase inhibitors enhance endothelin-1 (ET-1)-induced contractions in human temporal artery, but not in porcine ophthalmic artery. Headache 1992;32(10):475-479.
70. Dahl A, Russell D, Nyberg-Hansen R, Rootwelt K. Cluster headache: Transcranial Doppler ultrasound and rCBF studies. Cephalalgia 1990;10(2):87-94.
71. Moskowitz MA. Interpreting vessel diameter changes in vascular headaches. Cephalalgia 1992;12(1):5-7.
72. Moskowitz MA, Brody M, Liu-Chen LY. In vitro release of immunoreactive substance P from putative afferent nerve endings in bovine pia arachnoid. Neuroscience 1983;9(4):809-814.
73. Buzzi MG, Carter WB, Shimizu T, Heath H III, Moskowitz MA. Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion. Neuropharmacology 1991;30(11):1193-1200.
74. Buzzi MG, Moskowitz MA. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol 1990;99(1):202-206.
75. Buzzi MG, Moskowitz MA, Peroutka SJ, Byun B. Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater. Br J Pharmacol 1991;103(2):1421-1428.
76. Nozaki K, Moskowitz MA, Boccalini P. CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges. Br J Pharmacol 1992;106(2):409-415.